1. Trang chủ
  2. » Luận Văn - Báo Cáo

Báo cáo khoa học: Effect of 5-lipoxygenase inhibitor MK591 on early molecular and signaling events induced by staphylococcal enterotoxin B in human peripheral blood mononuclear cells doc

11 470 0

Đang tải... (xem toàn văn)

Tài liệu hạn chế xem trước, để xem đầy đủ mời bạn chọn Tải xuống

THÔNG TIN TÀI LIỆU

Thông tin cơ bản

Định dạng
Số trang 11
Dung lượng 264,82 KB

Các công cụ chuyển đổi và chỉnh sửa cho tài liệu này

Nội dung

Signaling activities, inhibitor studies, cellular analysis and gene expression analysis in unison illustrated the significance of pathway inter-connectors such as 5-LO as well as inhibiti

Trang 1

molecular and signaling events induced by staphylococcal enterotoxin B in human peripheral blood mononuclear

cells

Chanaka Mendis1, Katherine Campbell1, Rina Das2, David Yang3and Marti Jett2

1 Department of Chemistry and Engineering Physics, University of Wisconsin-Platteville, WI, USA

2 Department of Molecular Pathology, Walter Reed Army Institute of Research, Silver Spring, MD, USA

3 Department of Chemistry, Georgetown University, Washington, DC, USA

Staphylococcal enterotoxin B (SEB) is one of the many

exotoxins produce by Staphylococcus aureus and is

implicated in inducing diarrhea, vomiting, muscle

numbness, possible involvement in autoimmune

disor-ders and lethal shock [1] The massive impact of T cell

activation, proliferation, and cytokine production by

CD4+T cells via specific Vbelements of T cell antigen

receptor [2] has prompted a number of investigations

to focus on the intricate signaling activities of SEB

Even though the molecular events of SEB-induced lethal shock in human peripheral blood mononuclear cell (PBMCs) are not very apparent, the actual response of lethal shock is expected to herald by changes in signaling pathways [3,4] In mammalian cells, a variety of stimuli generate intracellular responses that converge on a limited number of compo-nents of multiple pathways [5] Mitogen-activated pro-tein kinase (MAPK) cascades together with arachidonic

Keywords

cross-talk; MK591; pathway

inter-connectors; signal transduction;

staphylococcal enterotoxin B

Correspondence

C Mendis, Department of Chemistry and

Engineering Physics, University of

Wisconsin-Platteville, 308, Ottensman Hall,

1 University Plaza, Platteville, WI, USA

Fax: +1 608 342 1559

Tel: +1 608 342 1692

E-mail: mendisc@uwplatt.edu

(Received 5 December 2007, revised 9 April

2008, accepted 11 April 2008)

doi:10.1111/j.1742-4658.2008.06462.x

Staphylococcal enterotoxin B (SEB) has been the focus of a number of stu-dies due to its ability to promote septic shock and a massive impact on the human immune system Even though symptoms and pathology associated with SEB is well known, early molecular events that lead to lethality are still poorly understood Our approach was to utilize SEB induced human peripheral blood mononuclear cells (PBMCs) as a prototype module to further investigate the complexity of signaling cascades that may ultimately lead to lethal shock Our study revealed the activation of multiple divergent intracellular pathways within minutes of SEB induction including compo-nents that interconnect investigated pathways A series of performed inhibi-tor studies identified a specific inhibiinhibi-tor of 5-LO (MK591), which has the ability to block JNK, MAPK, p38kinase and 5-LO signaling-cascades and drastically reducing the activity of pro-inflammatory cytokine TNF-a Further evaluation of MK591 utilizing cell proliferation assays in PBMCs, human proximal tubule cells and in vivo studies (monkey) showed a decrease in cell proliferation The inhibitory effect of MK591 was recon-firmed at a genetic level through the utilization of a set of SEB specific genes Signaling activities, inhibitor studies, cellular analysis and gene expression analysis in unison illustrated the significance of pathway inter-connectors such as 5-LO as well as inhibiting such inter-inter-connectors (using MK591) in SEB induced human PBMCs

Abbreviations

5-LO, 5-lipoxygenase; HIF, hypoxia-inducible factor; IL, interleukin; JNK, c-Jun N-terminal kinase; MAPK, mitogen-activated protein kinase; p38kinase, p38-mitogen activated protein kinase; PBMC, peripheral blood mononuclear cell; REPTC, renal epithelial proximal tubular cell; SEB, staphylococcal enterotoxin B; TNF, tumor necrosis factor.

Trang 2

acid metabolic cascades comprise one of the major

sig-naling systems efficiently utilized by cells to transmit

and integrate a plethora of intracellular activities [6]

Although the well regulated signal transduction is

cru-cial for typical cell behavior, aberrant signaling often

leads to diverse pathological consequences Even

though cross-talk is not a novel concept, the induction

of multiple signal cascades and the inter-connectivity of

SEB-induced cascades in human PBMCs have not been

examined in detail To gather evidence vital in

identify-ing early signalidentify-ing events triggered by super-antigen

SEB in lethal shock, we examined the SEB-induced

signaling and cross-talk activities of 5-lipoxygenase

(5-LO), MAPK, c-Jun N-terminal kinase (JNK) and

p38-mitogen activated protein kinase (p38kinase)

pathways

A number of signaling cascades have been

docu-mented in which a series of proteins activate and

regu-late one another in a sequential and cooperative

fashion [7,8] One such protein kinase cascade known

as MAPK is activated in cells responsive to various

stimuli, predominantly growth factors [9] MAPKs

have a molecular mass of 40–44 kDa and are activated

by the phosphorylation of both threonine and tyrosine

residues conserved in the threonine-glutamate-tyrosine

motif [10] P38kinases are induced by a plethora of

acti-vators including and not limited to UV light, heat,

osmotic shock, inflammatory cytokines [tumor necrosis

factor (TNF)-a and interleukin (IL)-1] and growth

fac-tors (colony-stimulating factor-1) [11–13] Similar to

p38kinase and MAPK, JNK contains a dual

phosphor-ylation motif and is induced by stress-inducing agents

or pro-inflammatory cytokines [14] The arachidonic

acid signaling pathway, which has been studied in great

detail, is known to up-regulate inflammatory responses

and 5- and 15-hydroxyeicosatetraenoic acid metabolites

in human T cells and human lymphocytes, respectively

[6] Products of the arachidonic acid metabolizing

enzyme 5-LO have been shown to stimulate the growth

of several types of cancers, whereas 5-LO activating

protein inhibitor MK-886 has shown to inhibit cell

growth in a dose- and time-dependent manner in a

gas-tric cancer cell line [15] Recent evidence of arachidonic

acid signaling activities has indicated possible cross-talk

of 5-LO and cyclooxygenase-2 through the cysteinyl

leukotriene receptor 2 in endothelial cells [16]

Superantigens are known to activate large families of

T cells based on expression of the Vb chain of the

T cell receptor, which in turn increases cell

prolifera-tion and pro-inflammatory cytokine secreprolifera-tion [1] The

present study aimed to investige the early signaling

events induced by SEB in human PBMCs to determine

the pathway inter-connectors We hypothesized that

such signaling inter-connectors can be effectively targeted to terminate⁄ reduce aberrant signaling and cel-lular activities that may ultimately lead to SEB-induced lethal shock Our goal was to evaluate multiple signal-ing cascades induced by SEB and target pathway inter-connector 5-LO to inhibit unwanted cellular activities

As multiple investigations have effectively utilized systematic examination of gene expression profiles by stimulants to reveal qualitative and quantitative differ-ences that may ultimately lead to possible mechanisms

of action [17,18], we further evaluated the inhibitory effect of 5-LO specific inhibitor (MK591) at a genetic level by analyzing the gene expression pattern of a set

of SEB specific genes that explain some of the SEB-induced symptoms via gene functions

Results

Effect of SEB on multiple signal transduction pathways in human PBMCs

Even though the ability of SEB to induce lethal shock

is known, the mechanism of its action remains unclear

In the present study, we analyzed the activation of various proteins kinases in response to SEB aiming to better understand the intricacy of signaling activities

Effect on MAPK Human PBMCs at a cell density of 2.5 millionÆmL)1 were treated with 100 ngÆmL)1 of SEB for different time periods and MAPK phosphorylation was quanti-tated as described in the Experimental procedures When stimulated with SEB, MAPK phosphorylation (activation) was visible by as early as 1 min, showed maximum activity after 5 min (2.8-fold) and finally returned to control levels by 60 min (Figs 1 and 2)

Effect on p38kinase Human PBMCs were treated with SEB and the activa-tion of p38kinase was measured as described in the Experimental procedures An initial burst of activation

of this stress-induced kinase was seen by as early as

1 min after exposure (two-fold), followed by a slight increase up to 5 min (2.25-fold) and reached control levels by 60 min (Figs 1 and 2)

Effect on JNK

As SEB is known to induce a stress response in human PBMCs, we examined the effect of SEB on the activity

of stress-induced kinase (JNK), also known as stress

Trang 3

activated protein kinase, using two different techniques

(immunoblots and kinase assays) Our immunoassay

results indicated a rapid five-fold activation of JNK

within 5 min of SEB exposure (Figs 1 and 2) A

two-fold JNK activity was observed even at 60 min Even

though SEB-induced samples analyzed for JNK

activa-tion using kinase assays did show higher activaactiva-tion

than control levels, high background levels interfered

with any proper quantification of the activity (Fig 1)

Effect on 5-LO

Our experiments confirmed a time-dependent

activa-tion of 5-LO, showing a maximum activity of two-fold

within 5 min and sustaining activity levels slightly

above control levels at 60 min (Figs 1 and 2)

Comparison of SEB triggered signaling cascades

Comparison of multiple signal transduction pathways

revealed that all investigated pathways showed a

rela-tively similar time-dependent protein activation

pat-tern, with a few differences unique to each key

pathway (Fig 2) All four analyzed components

(p38kinase, 5-LO, JNK and MAPK) showed maxi-mum activity by 5 min At 5 min, JNK activity was at least two-fold higher than the activity of the rest of the components and continued to show activity over con-trol levels (compared to other components) throughout the study period (0–60 min) JNK and 5-LO showed 2.25-fold and 1.5-fold activity, respectively, at 60 min

Effect of various inhibitors on SEB triggered signaling cascades

Previous experiments carried out in our laboratory have shown the involvement of eicosanoids in SEB-induced shock in human lymphoid cells In the present study, we expanded the investigation to include inhibi-tors of various signal transduction pathways such as lipoxygenase inhibitors (MK886, MK591 and curcu-min), p38kinase inhibitor (SB203580), JNK inhibitor (SP600125) and MAPK inhibitor (PD98059) to observe the effect in human PBMCs As all investigated protein phosphorylation data indicated a maximum expression

at 5 min, we chose 5 min as the time point to investi-gate further the effect of all inhibitors All inhibitors of the lipoxygenase pathway were able to block SEB-induced MAPK and p38kinase activation but only had

a partial inhibitory effect on JNK activation (Table 1) MAPK inhibitor PD98059 had a negligible effect

on SEB-induced p38kinase, JNK and 5-LO activation, whereas p38kinase inhibitor SB203580 clearly blocked the induced MAPK and JNK activity, but did not effect the 5-LO activity Interestingly, JNK inhibitor SP600125 (1,9-pyrazoloanthrone) demonstrated attenu-ation of SEB-induced MAPK expression yet had no effect on p38kinase or 5-LO activation

Fig 2 Comparison of signaling pathway activation profiles A com-parison of the time-dependent activation of 5-LO, MAPK, JNK and p38kinase is shown Activation of samples at multiple time points (1, 5, 30 and 60 min) was quantitated using NIH IMAGE software and data are shown as triplicates with the respective SD values.

Fig 1 SEB-induced activation of signaling cascades in human

PBMCs Human PBMCs at 2.5 · 10 6

cellsÆmL)1were treated with SEB and the activation of each of the key elements was quantitated

by immunoassays as described in the Experimental procedures.

Phosphorylation of all samples except JNK were analyzed using

im-munoassays whereas JNK was quantitated using both kinase and

immune-assays; 0, 1, 5, 30 and 60 refer to the time (min) PBMCs

were exposed to SEB 0, PBMCs not exposed to SEB but subjected

all other experiment parameters (control sample).

Trang 4

Effect of inhibitors on SEB-induced TNF-a

induction

The investigation then focused on analyzing the

effect of the same set of inhibitors on TNF-a

induc-tion (Table 1) The observed inducinduc-tion in SEB

trea-ted cells (22-fold) was drastically reduced in cells

treated with various inhibitors Of the different

inhibitors, SB203580 showed the highest inhibitory

effect (1.5-fold) whereas MK886 and MK591 (5-LO

inhibitors) showed a slightly lower inhibition than

SB203580 Even though all the inhibitors (Table 1)

used in this study had a somewhat inhibitory effect

on TNF-a expression, the effect of both PD98059

and SP600125 was minimal compared to the other

inhibitors

Effect of inhibitors on SEB-induced PBMC

proliferation

Figure 3 illustrates the concentration effect of SEB on

human PBMC proliferation We observed that

prolifera-tion was directly proporprolifera-tional to SEB concentraprolifera-tion in

the range 10–110 ngÆmL)1 For SEB concentration in

the range 0–10 ngÆmL)1, a slight drop in cell

prolifera-tion was observed whereas SEB concentraprolifera-tions higher

than 110 ngÆmL)1showed an increase in cell

prolifera-tion at a much lower rate Both MK591 and SB203580

were able to block SEB-induced cell proliferation

(Table 2)

Effect of SEB and 5-LO inhibitor MK591 on

human renal epithelial proximal tubular cells

(REPTC) proliferation

SEB-treated REPTC proliferation was partially

inhib-ited by MK591 (33%) whereas SB203580 had no effect

on REPTC proliferation (Table 2)

Table 1 Effect of various inhibitors on SEB-induced signaling pathways Human PBMCs (2.5 · 10 6 cellsÆmL)1) were treated with the respective inhibitor for 30 min at 37 C prior to a 5 min stimulation with SEB at 37 C All inhibitors were used at 20 l M except SB203580 and SP600125, which were used at 10 l M All values are shown as a percent of control samples TNF-a induction is referred to as the acti-vation of TNF-a when induced by100 ngÆmL)1SEB for 5 min ND, not determined.

SEB (ng·ml –1 )

3 H labeled thymidine

0 2000 4000 6000 8000

10 000

12 000

14 000

16 000

Fig 3 Concentration dependence of SEB on PBMC proliferation A typical SEB-induced time-dependent cell proliferation pattern is shown Human PBMCs at 2.5 · 10 6 cellsÆmL)1density were incu-bated in 96-well plates in the presence of SEB at various concen-trations (range: 1–200 ng) and incorporated radioactivity, which is directly proportional to cell proliferation, was quantitated as described in the Experimental procedures.

Table 2 Effectiveness of MK591 on SEB stimulated cellular activi-ties Each cell type was treated with MK591 for 30 min at 37 C prior

to the 5 min stimulation with SEB at 37 C All in vitro experiments were performed at concentrations of 10 l M SB203580 and 20 l M

MK591 All in vivo experiments were performed at 10 m M Ækg)1 (SB203580) and at 20 m M Ækg)1(MK591) and the values are shown

as a percent of control samples ND, not determined Monkeys were exposed to saline or SEB (15 lgÆkg)1) by aerosol, with or without the treatment of the respective inhibitor and whole blood was collected after 30 min of exposure All cell proliferation experiments were carried out as described previously [31] and TNF-a experiments were carried out as described in the Experimental procedures.

Stimulant

T cell proliferation

in PBMC (%)

Proliferation

of REPTC (%)

T cell proliferation in monkeys (%)

TNF-a in monkeys (%)

MK591 14.67 ± 1.22 67.5 ± 2.5 45.2 ± 2.8 38.5 ± 2.5

Trang 5

Effect of 5-LO inhibitor MK591 on monkeys

challenged with SEB

Findings of in vitro studies of human PBMCs were

veri-fied in PBMCs isolated from aerosol SEB challenged

monkeys The animals were treated with a sublethal

dose of the toxin, which caused incapacitation Each

monkey was used as its own control in a saline sham

experiment TNF-a and T cell proliferation was assayed

from blood samples as early as 30 min post exposure

MK591 was able to inhibit the expression of TNF-a

and T cell proliferation in vivo samples (Table 2)

Effect of MK591 on the expression of a set of

SEB specific genes

To examine our hypothesis of effectively targeting a

pathway inter-connector to block the SEB-induced

sig-naling cascades, we evaluated MK591 at a genetic level

by analyzing a set of SEB specific genes Genes that

were chosen based on functional significance were

ana-lyzed by performing RT-PCR at 2 h and 16 h

(Table 3) Three genes [for cathepsin L, IL-17 and

gua-nylate binding protein (GBP)-2] that are up regulated

by SEB were all down regulated by MK591 at 16 h

All three genes showed a reduction in the activation as

early as 2 h whereas the gene for IL-17 showed a

four-fold down regulation at 2 h CTAP-III, which is down

regulated by SEB both at 2 h and 16 h, showed an up

regulation at 16 h with MK591 The effect of MK591

on proteoglycan V0was minimal at both 2 h and 16 h

Discussion

Despite many decades of extensive investigation,

nei-ther the exact pathomechanism, nor the intricate

nature of SEB-induced signaling activities are well

understood The mode of signal transduction is vital in properly understanding the multifunctional role of staphylococcal enterotoxin as a super-antigen [1] A recent study has revealed phosphatase-mediated crosstalk between MAPK signaling pathways in the regulation of cell survival [19] Although crucial to understanding cell survival, the investigation does not provide any information about the importance of tar-geting pathway inter-connectors The present study aimed to investigate a group of multiple signal trans-duction pathways in human PBMCs (i.e the first line

of defense encountered by foreign substances) using a single stimulant (SEB) to better comprehend and visu-alize the complexity of signal transduction pathways Protein activation experiments indicated the ability of SEB to induce multiple signaling pathways as well as high activation levels of JNK This result lead us to hypothesize that SEB may utilize a single pathway to transmit majority of the signal but can use multiple cascades at varying strengths depending on the time, stimulant and availability of pathways The concept has many interesting consequences; specifically, whether an extracellular stimulant may lead to aber-rant cellular behavior In such a case, it is important

to look at all possible signal transduction pathways when deducing the key element or elements that may abolish such a signal

To further investigate the activation of multiple sig-nal transduction pathways and to explore the exis-tence of pathway inter-connectors, we performed a series of inhibitor studies targeting MAPK, p38kinase, 5-LO and JNK Previous investigations carried out in our laboratory have indicated the inhibition of SEB-induced arachidonic acid and MAPK activation in human lymphoid cells by 5-LO inhibitors such as curcumin, NDGA and MK881 (C Mendis, R Das,

D Yang and M Jett, unpublished results) whereas

Table 3 Effect of MK591 on the expression of a set of SEB specific genes A set of SEB specific genes previously identified by differential display-PCR and RT-PCR (18) were further examined using 5-LO inhibitor MK591 After designing specific primers for each gene of interest, RT-PCR reactions were performed on samples treated with SEB (100 ngÆmL)1) with or without the inhibitor (MK591) for 2 h and 24 h as described in the Experimental procedures Identical total RNA samples were used for all analysis, and the bands of PCR products were digi-tized after normalizing with a house keeping gene (18S rRNA), and quantitated using NIH IMAGE software All reactions were repeated twice and the results are reported as mean ± SD values relative to the control CTAP-III, connective tissue activating protein III; CTSL, cathepsin L transcript variant1 mRNA; Prot-V0, chondroitin sulfate proteoglycan versican V0splice-variant precursor peptide ND, not determined.

Trang 6

cross-talk of p38kinase and MAPK has been

observed in d-glucose-induced cell death [20] Our

results demonstrated the ineffectiveness of targeting

MAPK inhibitor PD98059 because the inhibitor had

no effect on the activities of JNK, 5-LO or

p38kinase, which is somewhat similar to the results

obtained for PD98059 in IgG-opsonized sheep

eryth-rocyte-stimulated polymorphonuclear leukocytes [21]

The ability of p38kinase inhibitor SB203580 to

selec-tively and markedly inhibit SEB stimulated MAPK

and JNK activation suggested interconnectivity of

p38kinase, MAPK and JNK pathways, but no

indi-cation of any effect on the 5-LO pathway Even

though SEB-induced JNK phosphorylation far

exceeded the activation of other pathways, JNK

spe-cific inhibitor SP600125 was only able to inhibit

MAPK activation

The above results led us to continue our inhibitor

study targeting the 5-LO pathway, specifically

MK591 Targeting the 5-LO pathway using MK591

attenuated all previously observed activation of the

MAPK, p38kinase and JNK pathways The multiple

pathway inhibitory effects of MK591 confirmed the

importance of 5-LO as a pathway inter-connector in

SEB-induced human PBMCs Similar results were

observed in vascular smooth muscle cells, in which

JNK-1 and MAPK were induced by arachidonic acid

in a time- and concentration-dependent manner [22]

Figure 4 illustrates the inter-connectivity of signaling cascades that participat7e in SEB-induced human PBMCs

Both human and animal models of endotoxin-induced shock are similar, and both show an elevation

of pro-inflammatory cytokines (e.g TNF-a levels) within a few hours of induction, followed by a decline

to undetectable levels [23] Inflammatory cytokine TNF-a is produced in SEB-induced human PBMCs to

a 50-fold greater extent than in untreated cells [24], modulating a wide variety of cellular processes such as organ dysfunction and systematic shock [25–28] High induction of TNF-a SEB in human PBMCs prompted

us to utilize TNF-a as a cellular marker to further investigate the effect of MK591 TNF-a levels that were drastically elevated by 100 ngÆmL)1 SEB in human PBMCs were reduced back to control levels by 5-LO activating protein specific inhibitor MK591 (Table 1) Although intriguing, these results were based

on in vitro experiments and did not reveal any infor-mation under physiological conditions Further investi-gation of MK591 using an in vivo model (monkey) did show a similar pattern to that observed in vitro experi-ments, but not at similar levels of inhibition

One of the major characteristic of SEB-induced human PBMCs is the ability to show massive T cell proliferation Once exposed, PBMCs show a minimum 30% increase in T cell production We took advantage

5-LO

X

X

X

MAPK

X

X

TNF- α

X

GBP-2 Vasodilation

X

Cell proliferation

X

Vascular permability

X

Tissue degredation

X

HIF-1 Respiratory distress

X

IL-17 Inflammation

SEB complex

p38 JNK

CA-L

CTAP-III

Fig 4 Schematic diagram of the inhibitory

effect of MK591 on SEB-induced human

PBMCs The inter-connectivity of

SEB-induced signaling cascades as well as the

effectiveness of 5-LO inhibitor MK591 is

shown, in addition to the inhibitory effect of

MK591 on a set SEB specific proteins and

genes All genes are indicated by a double

outline around the name together with the

corresponding functionally related symptom

of SEB All proteins are indicated by a single

outline around the name Symbol ‘X’

indi-cates inhibition of a protein or gene activity.

CTAP-III, connective tissue activating protein

III; CA-L, cathepsin L transcript variant1

mRNA.

Trang 7

of the high activation of T cells and used it as our

sec-ond parameter to evaluate the effectiveness of MK591

Our results clearly indicated the ability of MK591 to

efficiently inhibit SEB-induced T cell proliferation

in vitro, and the 50% T cell inhibition observed in a

monkey model further solidified the high potency of

the inhibitor (Table 2 and Fig 4) Evidence from

experiments performed using animal models implicates

the kidney in general, and the REPTCs in particular,

as the major target of SEB uptake It is also clear that

70% of injected SEB is accumulated in proximal

tubule cells within 2 h [29–31] of stimulation Based on

the evidence of kidney involvement in blood pressure

regulation, it is not unreasonable to hypothesize that

damage to the renal epithelium caused by a vascular

shock-inducing agent, such as SEB (which possesses

the ability to interact directly with the vascular

tone-regulating kidney cells), may contribute to the

develop-ment of systemic shock (unpublished results) The

functional significance of REPTCs prompted us to

further investigate whether MK591 had any inhibitory

effect on REPTCs; if this is the case, we believe that

targeting 5-LO with MK591 may even help reduce

sys-temic shock The ability of MK591 to effectively

inhi-bit T cell as well as REPTC (by 33%) proliferation

indicates for the first time the effectiveness of targeting

a pathway inter-connector (5-LO) It is possible that

the ability of the target to inter-connect multiple signal

pathways allowed it to influence cellular activity in the

two crucial cell types that are most effected by SEB

stimulation SB203580, an inhibitor of pathway

inter-connector p38kinase, had a similar inhibitory effect on

T cell proliferation but did not inhibit REPTCs, which

is known to function as a major target of SEB uptake

The result prompted us to focus further on evaluating

MK591 as a possible inhibitor

We then investigated the effect of MK591 on the

expression pattern of a set of SEB specific genes that

somewhat explained the symptoms induced by SEB via

gene functions We believed that the gene analysis

would further complement and validate the inhibitory

effects observed for MK591 at a protein level [18]

Some of the investigated genes are involved in

func-tions such as inflammation (IL-6 and IL-17), tissue

damage⁄ cardiac dysfunction (cathepsin L), hypoxia

inducible conditions [hypoxia-inducible factor

(HIF)-1], alterations to the physiology of blood vessels

(pro-teoglycan V0) and vasodilatation (GBP-2) Our target

MK591 was able to alter the expression of each of the

above SEB specific genes at two time points (2 h and

16 h) as shown in Table 3, except proteoglycan V0

(which did not show alteration at both time points)

and IL-6 (uncompleted experiments) All of the above

genes have been thoroughly investigated and contrib-ute to a profile that is specific for SEB [18] Even though RT-PCR is considered to be a semi-quantita-tive gene quantification method, the results observed are significant for two reasons The purpose of the analysis was, first, to verify whether MK591 was able

to alter a SEB specific gene profile and, second, to evaluate the effectiveness of MK591 at both protein and genetic levels Our investigation showed the abil-ity of SEB to utilize multiple signaling cascades to induce cell proliferation and TNF-a induction, which ultimately would result in symptoms such as inflamma-tion, respiratory distress, tissue degradainflamma-tion, vascular permeability and vasodilation Our model (Fig 4) shows the effect of targeting multi-pathway inter-con-nector 5-LO by a specific inhibitor (MK591) and sum-marizes the alterations observed at the genetic level and the inhibitory effects observed at the protein level The model signifies the importance of targeting components such as 5-LO that have the ability to inter-connect multiple signaling cascades such as JNK, p38kinase and MAPK We believe that targeting 5-LO may have a wider impact on SEB-induced cellu-lar events than targeting a component such as p38kinase, which influences only JNK and MAPK and not 5-LO The inability of p38kinase inhibitor to block 5-LO activity may have played a role in the inability

of SB203580 to effectively block proliferation of REPTC

Potential signal blockers have to be examined thoroughly because time and again these targets have proven to be unsuccessful in clinical trials This can

be due to a number of reasons, including the inability

of the targets to completely block the signaling cascades due to the leaking effect or the ability of the signal to use alternative signaling cascades upon the inhibition of the primary signaling pathway We are confident that the ability of our target to function as a pathway inter-connector may have a positive influence

on blocking the SEB-induced signaling activities Fur-thermore, it is important to reconfirm the inhibition

of signaling activities observed for SEB to somewhat similar toxins such as lipopolysaccharides to better understand whether the inter-connector has a universal function We have previously compared the gene expression pattern of SEB and lipopolysaccharides and know that each profile is remarkably different than the other, even though both tend to induce similar symptoms in exposed patients [18] We are currently analyzing the protein activation pattern of the two toxins to differentiate specific signaling activities as well as identify similar signaling activities (data not included)

Trang 8

Knowledge on the early molecular events

investi-gated in the present study will have a tremendous

impact on determining the effects of SEB on human

PBMCs and may complicate the finding of a

therapeu-tic target even more However, the emergence of

effec-tively targeting convergence points (5-LO) in this

intricate web of pathways has helped with respect to

finding targets that may have potential therapeutic

sig-nificance The early identification of these key elements

will also help in determining the potential exposure to

SEB before a patient experiences significant damage

and, undoubtedly, will be key in designing strategies to

block or even limit aberrant signaling cascades by

inhibiting pathway inter-connectors such as 5-LO

Even though, collectively, the above data comprise an

attempt to elucidate the complexity of signal

trans-duction pathways induced by SEB, the cross-talk of

pathways, and the effectiveness of inhibiting a pathway

inter-connector utilizing trademark cellular and genetic

activation patterns associated with SEB, further work

is essential, both in vivo and in vitro, to pinpoint the

efficiency and the effectiveness of MK591

Experimental procedures

Cells and cell cultures

Exposure of human PBMCs to SEB in vitro

Human PBMCs were collected from leukopacks from normal

donors as described previously [31] Human PBMCs with or

without SEB and⁄ or inhibitors of interest were used at a final

sup-plemented with 10% human AB serum Prior to treatment

and 60 min for protein extraction and 2 h and 16 h for RNA

extraction), PBMCs were incubated with an inhibitor of

interest at room temperature for 30 min at 20 lm, except

SP600125 and SB203580, which were used at 10 lm under

reagent (Life Technologies, Grand Island, NY, USA)

accord-ing to manufacturer’s instructions 0; PBMCs not exposed to

SEB but subjected to all other experiment parameters

Exposure of REPTC to SEB in vitro

Primary cultures of normal REPTCs from a 34-year-old

African-American male donor were obtained from Clonetics

(Walkersville, MD, USA) The cultures were maintained in

epithelial growth medium (Clonetics), supplemented with

vitamin solution (Gibco BRL, Grand Island, NY, USA) The cultures were maintained for up to seven passages and used for experiments after the second passage Cells were harvested and total RNA were isolated using Trizol reagent (Life Technologies) according to manufacturer’s instructions

Exposure of monkeys to aerosol challenge with SEB

blood samples and processing of blood samples were performed as described previously [31] Monkeys were

30 min after exposure PBMCs fractionated through a Ficoll gradient were then utilized in proliferation assays, TNF-a assays and total RNA isolations

Toxin

SEB from S aureus strain 10-275 purified by the method of [32] was provided in the lyophilized form by the US Army Research Institute of Infectious Diseases (Fert Detrick, Frederick, MD, USA) The stock solution was prepared in sterile, pyrogen-free deionized water at a concentration of

solution was diluted with cell culture medium to the desired concentration

Immunoblotting and western blotting

The cells were lysed after a brief sonication and incu-bated in the lysis buffer containing 20 mm Hepes, 10 mm

dithiothreitol, 150 mm NaCl, 2 mm sodium

OH, USA) or immunoprecipitated overnight with an

gels were transferred to poly(vinylidene difluoride) mem-branes (Invitrogen, Grand Island NY, USA), probed with

a specific antibody of interest (Santa Cruz Biotechnology, Santa Cruz, CA, USA), except JNK inhibitor which was purchased from Calbiochem (La Jolla, CA, USA) All immune assays were detected using an ECL detection kit (Amersham, Piscataway, NJ, USA), and quantitated using

MD, USA) All immunoblots and western blots were repeated at least three times to check for reproducibility and data are reported the mean ± SE

Trang 9

Proliferation assays

Human PBMCs were isolated and purified as described

pre-viously [31], except that human PBMCs were used at

with 10% human AB serum with or without the inhibitors

MK591 (20 lm) and SB203580 (10 lm) at SEB

sample Incorporated radioactivity was determined using a

microplate scintillation counter (Packard, Meriden, CT,

USA) All proliferation assays were repeated at least three

times for reproducibility Human REPTCs were also used

Kinase assays

Cell extracts were immunoprecipitated with p-JNK

anti-body (Santa Cruz Biotechnology) and washed with a kinase

20 mm b-glycerophosphate, 1 mm sodium orthovanadate,

2 mm dithiothreitol and 20 lm ATP Kinase assays were

performed using 2 lg of GST-c-Jun as substrate and

software All assays were performed at least three times to

verify reproducibility

ELISA immunoassays

Specific kits to quantitate TNF-a was purchased from

R&D systems and performed using equal amounts of

pro-teins obtained from human PBMCs or REPTCs with or

according to the manufacturer’s instructions (Quantikine

R&D systems, Minneapolis, MN, USA) All in vitro

experi-ments subjected to TNF-a assays were performed at

con-centrations of 10 lm SB203580 and 20 lm MK591 All

(MK591) Proteins were quantified using a Ceres UV

900-Hdi plate reader (Bio-Tek Instruments Inc., Winooski,

VT, USA) All samples other than the control samples were

incubated with SEB for 5 min

RT-PCR

RT-PCR analyses were performed using a Superscript

amplification kit (Life Technologies, Gaithersburg, MD,

USA) Housekeeping gene primers (18S) were obtained from

Clontech Corp (Palo Alto, CA, USA) and all primers were

designed using a primer-design software program named

(Applied Biosystems, Branchburg, NJ, USA) Genes were analyzed on 1% agarose gels, visualized through an inhouse imager and quantified using imagej (NIH Image) All cus-tom primers except 18S were purchased from Invitrogen (Carlsbad, CA, USA) All primers were designed to have an

for 35 cycles in a thermocycler (PerkinElmer, Waltham,

MA, USA) All sequences are indicated in the 5¢ to 3¢ direc-tion and are abbreviated after the gene name as ‘L’ or ‘R’ for reverse or forward, respectively CTAP-III-L; CAGCAA CTCACCCTCACTCA, CTAP-III-R; GTTTGTCCTTTGG TGGAGGA, CTSL-L; CATTTGCAGGCTCCTTTAGC,

GAAAGCGCAAGTCCTCAAAG, HIF-1-R; TGGGTAG GAGATGGAGATGC, GBP-2-L; GGTCCAGTTGCTGA AAGAGC, GBP-2-R; TGACAGGAAGGCTCTGGTCT, IL-6-L; TACCCCCAGGAGAAGATTCC, IL-6-R; TTT

AND IL-17-R; TTCCAAAGATGTAGCCGCCC

Acknowledgements

We like to extend our gratitude to Michael Hartl and Carla Sanchez [Walter Reed Army Institute of Research (WRAIR), Silver Spring, MD, USA] for their technical expertise in carrying out protein expres-sion analysis, Boris Ionin (WRAIR) for his assistance

in working with REPTC and a monkey model and Mark Hiner (University of Wisconsin Platteville) for his assistance in optimizing the gene quantitative anal-ysis technique We would also like to thank the University of Wisconsin-Platteville for its internal funding opportunities (SAIF and PURF grants) and Professor James Hamilton of the UWP Chemistry and Engineering Department for developing an imager to quantitate gene expression Research was conducted in compliance with the Animal Welfare Act and other federal statutes and regulations relating to animals and experiments involving animals and adheres to princi-ples stated in the Guide for the Care and Use of Laboratory Animals, NRC Publication, 1996 edition The opinions, interpretations, conclusions and recom-mendations are those of the author and are not neces-sarily endorsed by the US Army

References

1 Jett M, Ionin B, Das R & Neil R (2001) The staphylo-coccal enterotoxins The Encyclopedia of Molecular Medicine New York, NY: John Wiley & Sons, Inc., 5:

p 1089–1106

Trang 10

2 Torres BA, Perrin GQ, Mujtaba MG, Subramaniam

PS, Anderson AK & Johnson HM (2002) Superantigen

enhancement of specific immunity: antibody

production and signaling pathways J Immunol 169,

2907–2914

3 Marrack P & Kappler J (1990) The staphylococcal

enterotoxins and their relatives Science 248, 705–711

4 Cole B & Wells J (1990) Immunosuppressive properties

of the mycoplasma arthritis T-cell mitogen in vivo:

inhi-bition of proliferative responses to T-cell mitogens

Infect Immun 58, 228–236

5 Saxena M, Williams S, Tasken K & Mustelin T (1999)

Crosstalk between cAMP-dependent kinase and MAP

kinase through a protein tyrosine phosphatase Nat Cell

Biol 1, 305–311

6 Avis MI, Jett M, Boyle T, Vos DM, Moody T, Treston

MA, Martinez A & Mulshine L (1996) Growth control

of lung cancer by interruption of

5-lipoxygenase-medi-ated growth factor signaling J Clin Invest 97, 806–813

7 Cobb MH, Boulton TG & Robbins DJ (1991)

Extracel-lular signal-regulated kinases: ERKs in progress Cell

Regul 2, 965–978

8 Blenis J (1993) Signal transduction via the MAP

kinas-es: proceed at your own RSK Proc Natl Acad Sci USA

90, 5889–5892

9 Das R & Vonderhaar BK (1996) Activation of raf-1,

MEK, and MAP kinase in prolactin responsive

mam-mary cells Breast Cancer Res Treat 40, 141–149

10 Mertens S, Craxton M & Goedert M (1996) SAP

kinase-3, a new member of the family of mammalian

stress-activated protein kinases FEBS Lett 383, 273–

276

11 Rouse J, Cohen P, Trigon S, Morange M,

Alonso-Llamazares A, Zamanillo D, Hunt T & Nebreda AR

(1994) A novel kinase cascade triggered by stress and

heat shock that stimulates MAPKAP kinase-2 and

phosphorylation of the small heat shock proteins Cell

78, 1027–1037

12 Han J, Lee D, Bibbs L & Ulevitch J (1994) A MAP

kinase targeted by endotoxin and hyperosmolarity in

mammalian cells Science 265, 808–811

13 Freshney NW, Rawlinson L, Guesdon F, Jones E,

Cowley S, Hsuan J & Saklatvala J (1994)

Interleukin-1 activates a novel protein kinase cascade

that results in the phosphorylation of Hsp27 Cell 78,

1039–1049

14 Kyriakis JM & Avruck J (1996) Sounding the alarm:

protein kinase cascades activated by stress and

inflam-mation J Biol Chem 271, 24313–24316

15 Fan XM, Tu SP, Lam SK, Wang WP, Wu J, Wong

WM, Yuen MF, Lin MC, Kung HF & Wong BC

(2004) Five-lipoxygenase-activating protein inhibitor

MK-886 induces apoptosis in gastric cancer through

upregulation of p27kip1 and bax J Gastroenterol

Hepa-tol 19, 31–37

16 Lo¨tzer K, Jahn S, Kramer C, Hildner M, Nu¨sing R,

cyclooxygenase-2 cross-talk through cysteinyl lenko-triene receptor 2 in endothelial cells Prostaglandins and other Lipid Mediators 84, 108–115

17 Boldrick JC, Alizadeh AA, Diehn M, Dudoit S, Liu

CL, Belcher CE, Botstein D, Staudt LM, Brown PO & Relman DA (2002) Stereotyped and specific gene expression programs in human innate immune responses

to bacteria Proc Natl Acad Sci USA 99, 972–977

18 Mendis C, Das R, Hammamieh R, Royaee A, Yang D, Peel S & Jett M (2005) Transcriptional response signa-ture of human lymphoid cells to staphylococcal entero-toxin B Genes Immun 6, 84–94

19 Junttila MR, Li SP & Westermarck J (2008) Phospha-tase-mediated crosstalk between MAPK signaling path-ways in the regulation of cell survival FASEB J 22, 954–965

20 Nakagami H, Morishita R, Yamamoto K, Yoshimura

S, Taniyama Y, Aoki M, Matsubara H, Kim S, Kaneda

Y & Ogihara T (2001) Phosphorylation of p38 mitogen-activated protein kinase downstream of bax-caspase-3 pathway leads to cell death induced by high D-glucose

in human endothelial cells Diabetes 50, 1472–1481

21 Lenczowski JM, Dominguez L, Elder AM, King LB, Zacharchuk CM & Ashwell JD (1997) Lack of a role for Jun kinase and AP-1 in Fas-induced apoptosis Mol Cell Biol 17, 170–181

22 Hii CS, Ferrante A, Edwards YS, Huang ZH, Hartfield

PJ, Rathjen DA, Poulos A & Murray AW (1995) Acti-vation of mitogen-activated protein kinase by arachi-donic acid in rat liver epithelial WB cells by a protein kinase C-dependent mechanism J Biol Chem 270, 4201– 4204

23 Martich GD, Danner RL, Ceska M & Suffredini AF (1991) Detection of interleukin 8 and tumor necrosis factor in normal humans after intravenous endotoxin: the effect of antiinflammatory agents J Exp Med 173, 1021–1024

24 Yan Z, Yang DC, Neill R & Jett M (1999) Production

of tumor necrosis factor alpha in human T lymphocytes

by staphylococcal enterotoxin B correlates with toxin-induced proliferation and is regulated through protein kinase C Infect Immun 67, 6611–6618

25 Hale ML, Margolin SB, Krakauer T, Roy CJ & Stiles

BG (2002) Pirfenidone blocks the in vitro and in vivo effects of staphylococcal enterotoxin B Infect Immun

70, 2989–2994

26 Fast DJ, Schlievert PM & Nelson RD (1989) Toxic shock syndrome-associated staphylococcal and streptococcal pyrogenic toxins are potent inducers of tumor necrosis factor production Infect Immun 57, 291–294

27 Miethke T, Duschek K, Wahl C, Heeg K & Wagner H (1993) Pathogenesis of the toxic shock syndrome: T cell

Ngày đăng: 30/03/2014, 04:20

TỪ KHÓA LIÊN QUAN

TÀI LIỆU CÙNG NGƯỜI DÙNG

TÀI LIỆU LIÊN QUAN

🧩 Sản phẩm bạn có thể quan tâm